A. Huang

发表

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.

A. Branch, R. Dhanasekaran, C. Murphy, 2019, Gastroenterology.

Talk-time in the emergency department: duration of patient-provider conversations during an emergency department visit.

Barbara A. Buckley, James G. Adams, K. Cameron, 2014, The Journal of emergency medicine.

Non-selective Beta-Blockers in Decompensated Cirrhosis

B. Hameed, J. Gardner, A. Huang, 2020, Current Hepatology Reports.

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

A. Branch, R. Dhanasekaran, C. Murphy, 2019, Gastroenterology.

Direct‐acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local‐regional therapy or liver transplant waitlist dropout

N. Terrault, J. Dodge, N. Mehta, 2018, Hepatology.

The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study

N. Terrault, F. Durand, A. Elsharkawy, 2020, Transplantation.

Achalasia Quality Indicator Adherence

D. Leiman, Fouad Otaki, P. Kathpalia, 2022, Digestive Diseases and Sciences.

Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes

J. Dodge, M. Sarkar, R. Irani, 2021, The American journal of gastroenterology.

Direct-acting antivirals for hepatitis C do not increase the risk of hepatocellular carcinoma recurrence after locoregional therapy or liver transplant waitlist dropout

N. Terrault, J. Dodge, N. Mehta, 2017 .